Corporate Information | Press & Media | For Investors

ThinkGenetic

ThinkGenetic

Finding Patients At Risk for Rare Disease

  • Home
  • Solutions
    • FindEHR™
    • FindSM™
  • Research
    • Medical Publications
    • Technical Research
  • About
    • Team
    • Board
    • Partners
  • News & Events
  • Contact
  • Request a Demo

[Press Release] ThinkGenetic Announces Cian Robinson as Chief Revenue Officer to Focus on Growth and Partnership Opportunities

February 7, 2023 by Ruth O'Keefe

ThinkGenetic, Inc. (thinkgenetic.com) today announces the onboarding of entrepreneurial leader, Cian Robinson, MS, EdD-ABD as Chief Revenue Officer. Mr. Robinson is responsible for collaborating with potential ThinkGenetic clients to uncover opportunities for growth and partnership within ThinkGenetic.

Investor News, News, Press Releases Chief Revenue Officer, Cian Robinson, FindEHR, FindSM, investment, staff, Team, WORLDSymposium

[Audio Interview] ThinkGenetic Leadership Team Interview with RV Radio Part 2

December 16, 2022 by Ruth O'Keefe

In this second part, RV Radio continues the conversation with four members of the ThinkGenetic Leadership Team to focus the conversation on the day-to-day business and finding investment funding.

Investor News Cian Robinson, Dave Jacob, Dawn Laney, FindEHR, investment, Len Barker, podcast, Robinson Ventures, Ruth O'Keefe, RV Radio, startup, SymptomMatcher, ThinkGenetic

[Press Release] Massachusetts Startup Wins Horizon Prize, Powered by MIT Solve, with Algorithm-Based FindEHR Solution for Finding Undiagnosed Genetic Disorder Patients using Electronic Medical Records

October 7, 2021 by Ruth O'Keefe

ThinkGenetic combines modern machine learning with practical information in genetics to solve a major concern in healthcare – the identification of patients living with undiagnosed rare genetic conditions Boston, MA, […]

Investor News, News, Press Releases AI, algorithm, artificial intelligence, Boston startup, Dave Jacob, electronic health records, FindEHR, Horizon Prize, Horizon Therapeutics, machine learning, Massachusetts Institute of Technology, medical health records, MIT Solve, ThinkGenetic, Tim Walbert, undiagnosed patients

[Press Release] ThinkGenetic Selected as a Venture Atlanta 2021 Showcase Company

September 22, 2021 by Ruth O'Keefe

ThinkGenetic, Inc. announced today that it has been chosen out of a record-breaking 400-plus applicants as one of the top technology companies in the Southeast to be showcased at Venture Atlanta 2021.

Investor News, News, Press Releases Allyson Eman, Atlanta Startup Battle, Dawn Laney, FindEHR, ThinkGenetic, Venture Atlanta

[Press Release] Horizon Therapeutics plc Announces New Genetic Counselor Curated Algorithms and Next-Generation Sequencing Data as Winning Solutions of First-Ever Horizon Prize, Powered by MIT Solve, to Accelerate Rare Disease Diagnosis

September 21, 2021 by Ruth O'Keefe

Horizon Therapeutics plc (Nasdaq: HZNP), in collaboration with MIT Solve, a marketplace for social impact innovation, is proud to announce two winning solutions of this year’s Horizon Prize, ThinkGenetic Inc. and Congenica.

Investor News, News, Press Releases Alex Amouyel, algorithms, Congenica, Dave Jacob, FindEHR, funding, genetic counseling, global innovation challenge, Horizon Prize, Horizon Therapeutics, Innovation, Massachusetts Institute of Technology, MIT, MIT Solve, Rare Disease, ThinkGenetic, Tim Walbert

Upcoming Events

  • There are no upcoming events.

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

  • Solutions
    • FindEHR™
    • FindSM™
  • Resources
    • Contact
    • Research
    • FAQs
  • About ThinkGenetic
    • Team
    • Board
    • Investors
    • Careers
  • Legal
    • Disclaimers
    • Privacy Policy

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

©2023 ThinkGenetic. All Rights Reserved.